124 related articles for article (PubMed ID: 8847098)
1. Regulation of neurofibromin expression in rat sciatic nerve and cultured Schwann cells.
Wrabetz L; Feltri ML; Kim H; Daston M; Kamholz J; Scherer SS; Ratner N
Glia; 1995 Sep; 15(1):22-32. PubMed ID: 8847098
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the neurofibromatosis type 1 gene product, neurofibromin, during Schwann cell differentiation.
Gutmann DH; Tennekoon GI; Cole JL; Collins FS; Rutkowski JL
J Neurosci Res; 1993 Oct; 36(2):216-23. PubMed ID: 7505343
[TBL] [Abstract][Full Text] [Related]
3. Axons regulate the expression of Shaker-like potassium channel genes in Schwann cells in peripheral nerve.
Chiu SY; Scherer SS; Blonski M; Kang SS; Messing A
Glia; 1994 Sep; 12(1):1-11. PubMed ID: 7843783
[TBL] [Abstract][Full Text] [Related]
4. Axons modulate the expression of transforming growth factor-betas in Schwann cells.
Scherer SS; Kamholz J; Jakowlew SB
Glia; 1993 Aug; 8(4):265-76. PubMed ID: 8406683
[TBL] [Abstract][Full Text] [Related]
5. Tumorigenic properties of neurofibromin-deficient Schwann cells in culture and as syngrafts in Nf1 knockout mice.
Wu M; Wallace MR; Muir D
J Neurosci Res; 2005 Nov; 82(3):357-67. PubMed ID: 16180234
[TBL] [Abstract][Full Text] [Related]
6. Brain lipid binding protein in axon-Schwann cell interactions and peripheral nerve tumorigenesis.
Miller SJ; Li H; Rizvi TA; Huang Y; Johansson G; Bowersock J; Sidani A; Vitullo J; Vogel K; Parysek LM; DeClue JE; Ratner N
Mol Cell Biol; 2003 Mar; 23(6):2213-24. PubMed ID: 12612091
[TBL] [Abstract][Full Text] [Related]
7. Developmental regulation of NF1 tumor suppressor gene in human peripheral nerve.
Hirvonen O; Lakkakorpi J; Aaltonen V; Hirvonen H; Rossi M; Karvonen SL; Ylä-Outinen H; Kalimo H; Peltonen J
J Neurocytol; 1998 Dec; 27(12):939-52. PubMed ID: 10659684
[TBL] [Abstract][Full Text] [Related]
8. Spatially- and temporally-controlled postnatal p53 knockdown cooperates with embryonic Schwann cell precursor Nf1 gene loss to promote malignant peripheral nerve sheath tumor formation.
Hirbe AC; Dahiya S; Friedmann-Morvinski D; Verma IM; Clapp DW; Gutmann DH
Oncotarget; 2016 Feb; 7(7):7403-14. PubMed ID: 26859681
[TBL] [Abstract][Full Text] [Related]
9. Expression of Kit in neurofibromin-deficient human Schwann cells: role in Schwann cell hyperplasia associated with type 1 neurofibromatosis.
Badache A; Muja N; De Vries GH
Oncogene; 1998 Aug; 17(6):795-800. PubMed ID: 9715282
[TBL] [Abstract][Full Text] [Related]
10. Schwann cells from neurofibromin deficient mice exhibit activation of p21ras, inhibition of cell proliferation and morphological changes.
Kim HA; Rosenbaum T; Marchionni MA; Ratner N; DeClue JE
Oncogene; 1995 Jul; 11(2):325-35. PubMed ID: 7624147
[TBL] [Abstract][Full Text] [Related]
11. Reconstitution of the NF1 GAP-related domain in NF1-deficient human Schwann cells.
Thomas SL; Deadwyler GD; Tang J; Stubbs EB; Muir D; Hiatt KK; Clapp DW; De Vries GH
Biochem Biophys Res Commun; 2006 Sep; 348(3):971-80. PubMed ID: 16908010
[TBL] [Abstract][Full Text] [Related]
12. S100B and neurofibromin immunostaining and X-inactivation patterns of laser-microdissected cells indicate a multicellular origin of some NF1-associated neurofibromas.
Tucker T; Riccardi VM; Brown C; Fee J; Sutcliffe M; Vielkind J; Wechsler J; Wolkenstein P; Friedman JM
J Neurosci Res; 2011 Sep; 89(9):1451-60. PubMed ID: 21674567
[TBL] [Abstract][Full Text] [Related]
13. The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells.
Mashour GA; Ratner N; Khan GA; Wang HL; Martuza RL; Kurtz A
Oncogene; 2001 Jan; 20(1):97-105. PubMed ID: 11244508
[TBL] [Abstract][Full Text] [Related]
14. Connexin32 gene expression in rat sciatic nerves and cultured Schwann cells.
Satake M; Yoshimura T; Ohnishi A; Kobayashi T
Dev Neurosci; 1997; 19(2):189-95. PubMed ID: 9097034
[TBL] [Abstract][Full Text] [Related]
15. Expression of the neu proto-oncogene by Schwann cells during peripheral nerve development and Wallerian degeneration.
Cohen JA; Yachnis AT; Arai M; Davis JG; Scherer SS
J Neurosci Res; 1992 Apr; 31(4):622-34. PubMed ID: 1374476
[TBL] [Abstract][Full Text] [Related]
16. Normal rate of Schwann cell proliferation in the MBP-deficient shiverer mouse during Wallerian degeneration.
Komiyama A; Suzuki K
Brain Res; 1991 Nov; 563(1-2):345-8. PubMed ID: 1723925
[TBL] [Abstract][Full Text] [Related]
17. Expression of growth-associated protein-43 kD in Schwann cells is regulated by axon-Schwann cell interactions and cAMP.
Scherer SS; Xu YT; Roling D; Wrabetz L; Feltri ML; Kamholz J
J Neurosci Res; 1994 Aug; 38(5):575-89. PubMed ID: 7815473
[TBL] [Abstract][Full Text] [Related]
18. MiR-27a-3p/miR-27b-3p Promotes Neurofibromatosis Type 1 via Targeting of NF1.
Lu H; Liu P; Pang Q
J Mol Neurosci; 2021 Nov; 71(11):2353-2363. PubMed ID: 33570696
[TBL] [Abstract][Full Text] [Related]
19. Proteolipid protein mRNA stability is regulated by axonal contact in the rodent peripheral nervous system.
Jiang H; Duchala CS; Awatramani R; Shumas S; Carlock L; Kamholz J; Garbern J; Scherer SS; Shy ME; Macklin WB
J Neurobiol; 2000 Jul; 44(1):7-19. PubMed ID: 10880128
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of neurofibromin contributes to epithelial-mesenchymal transition in neurofibromatosis type 1.
Arima Y; Hayashi H; Kamata K; Goto TM; Sasaki M; Kuramochi A; Saya H
Exp Dermatol; 2010 Aug; 19(8):e136-41. PubMed ID: 20002172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]